Cirrhosis after orthotopic liver transplantation in the absence of primary disease recurrence

Liver Transplantation

Volumn 13, Issue 7, 2007, Pages 966-974

  Seyam, Moataz ^a   Neuberger, James M ^a   Gunson, Bridget K ^a   Hübscher, Stefan G ^b  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; PREDNISOLONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ALCOHOLIC FATTY LIVER; ALPHA 1 ANTITRYPSIN DEFICIENCY; AUTOIMMUNE HEPATITIS; CLINICAL FEATURE; DISEASE ASSOCIATION; FATALITY; FEMALE; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; POSTOPERATIVE COMPLICATION; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; REVIEW;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; FATTY LIVER; FATTY LIVER, ALCOHOLIC; HEPATITIS B; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34547478659     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21060     Document Type: Review

References (62)

1. Neuberger J. Liver transplantation. J Hepatol 2000;32: 198-207.
2. Neuberger J. Chronic allograft dysfunction: diagnosis and management. Is it always progressive? Liver Transpl 2005; 11(suppl):S63-S68.
3. Facciuto M, Heidt D, Guarrera J, Bodian CA, Miller CM, Emre S, et al. Retransplantation for late liver graft failure: predictors of mortality. Liver Transpl 2000;6:174-179.
4. Biggins SW, Beldecos A, Rabkin JM, Rosen HR. Retransplantation for hepatic allograft failure: prognostic modeling and ethical considerations. Liver Transpl 2002;8:313-322.
5. Tabatabai L, Lewis WD, Gordon F, Jenkins R, Khettry U. Fibrosis/ cirrhosis after orthotopic liver transplantation. Hum Pathol 1999;30:39-47.
6. Berenguer M, Ferrell L, Watson J, Prieto M, Kim M, Rayon M, et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 2000; 32:673-684.
7. Charlton M. The impact of advancing donor age on histologic recurrence of hepatitis C infection: the perils of ignored maternal advice. Liver Transpl 2003;9:535-537.
8. Rosen HR. Hepatitis B and C in the liver transplant recipient: current understanding and treatment. Liver Transpl 2001;7(suppl):S87-S98.
9. Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 1991;13:619-626.
10. Samuel D, Bismuth A, Mathieu D, Arulnaden JL, Reynes M, Benhamou JP, et al. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet 1991;337:813-815.
11. Hubscher SG, Elias E, Buckels JA, Mayer AD, McMaster P, Neuberger JM. Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation. J Hepatol 1993;18:173-184.
12. Liermarm Garcia RF, Evangelista Garcia C, McMaster P, Neuberger J. Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center. Hepatology 2001;33:22-27.
13. Harrison RF, Davies MH, Neuberger JM, Hubscher SG. Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis? Hepatology 1994;20:356-361.
14. Graziadei IW, Wiesner RH, Marotta PJ, Porayko MK, Hay JE, Charlton MR, et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 1999;30:1121-1127.
15. Solano E, Khakhar A, Bloch M, Quan D, McAlister V, Ghent C, et al. Liver transplantation for primary sclerosing cholangitis. Transplant Proc 2003;35:2431-2434.
16. Hubscher SG. Recurrent autoimmune hepatitis after liver transplantation: diagnostic criteria, risk factors, and out-come. Liver Transpl 2001;7:285-291.
17. Pageaux GP, Bismuth M, Perney P, Costes V, Jaber S, Possoz P, et al. Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter? J Hepatol 2003; 38:629-634.
18. Molloy RM, Komorowski R, Varma RR. Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation. Liver Transpl Surg 1997;3:177-178.
19. Sanjeevi A, Lyden E, Sunderman B, Weseman R, Ashwathnarayan R, Mukheijee S. Outcomes of liver transplantation for cryptogenic cirrhosis: a single-center study of 71 patients. Transplant Proc 2003;35:2977-2980.
20. Roche B, Samuel D, Gigou M, Feray C, Virot V, Schmets L, et al. De novo and apparent de novo hepatitis B virus infection after liver transplantation. J Hepatol 1997;26: 517-526.
21. Segovia R, Sanchez-Fueyo A, Rimola A, Grande L, Bruguera M, Costa J, et al. Evidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation. Liver Transpl 2001;7:106-112.
22. Feray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, et al. The course of hepatitis C virus infection after liver transplantation. Hepatology 1994;20:1137-1143.
23. Sebagh M, Rifai K, Feray C, Yilmaz F, Falissard B, Roche B, et al. All liver recipients benefit from the protocol 10-year liver biopsies. Hepatology 2003;37:1293-1301.
24. Heneghan MA, Portmarm BC, Norris SM, Williams R, Muiesan P, Rela M, et al. Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults. Hepatology 2001;34:464-470.
25. Mieli-Vergani G, Vergani D. De novo autoimmune hepatitis after liver transplantation. J Hepatol 2004;40:3-7.
26. Burke A, Lucey MR. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am J Transplant 2004;4:686-693.
27. Sebagh M, Farges O, Kalil A, Samuel D, Bismuth H, Reynes M. Sclerosing cholangitis following human orthotopic liver transplantation. Am J Surg Pathol 1995;19:81-90.
28. Nakazawa Y, Jonsson JR, Walker NI, Kerlin P, Steadman C, Lynch SV, et al. Fibrous obliterative lesions of veins contribute to progressive fibrosis in chronic liver allograft rejection. Hepatology 2000;32:1240-1247.
29. Nakhleh RE, Schwarzenberg SJ, Bloomer J, Payne,W, Snover DC. The pathology of liver allografts surviving longer than one year. Hepatology 1990;11:465-470.
30. Pappo O, Ramos H, Starzl TE, Fung JJ, Demetris AJ. Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Pathol 1995;19:192-206.
31. Rosenthal P, Emond JC, Heyman MB, Snyder J, Roberts J, Ascher N, et al. Pathological changes in yearly protocol liver biopsy specimens from healthy pediatric liver recipients. Liver Transpl Surg 1997;3:559-562.
32. Slapak GI, Saxena R, Portmann B, Gane E, Devlin J, Calne R, et al. Graft and systemic disease in long-term survivors of liver transplantation. Hepatology 1997;25:195-202.
33. Pessoa MG, Terrault NA, Ferrell LD, Detmer J, Kolberg J, Collins ML, et al. Hepatitis after liver transplantation: the role of the known and unknown viruses. Liver Transpl Surg 1998;4:461-468.
34. Davison SM, Skidmore SJ, Collingham KE, Irving WL, Hubscher SG, Kelly DA. Chronic hepatitis in children after liver transplantation: role of hepatitis C virus and hepatitis G virus infections. J Hepatol 1998;28:764-770.
35. Berenguer M, Rayon JM, Prieto M, Aguilera V, Nicolas D, Ortiz V, et al. Are posttransplantation protocol liver biopsies useful in the long term? Liver Transpl 2001;7:790-796.
36. Rifai K, Sebagh M, Karam V, Saliba F, Azoulay D, Adam R, et al. Donor age influences 10-year liver graft histology independently of hepatitis C virus infection. J Hepatol 2004;41:446-53.
37. Nakhleh RE, Krishna M, Keaveny AP, Dickson RC, Rosser B, Nguyen JH, et al. Review of 31 cases of morphologic hepatitis in liver transplant patients not related to disease recurrence. Transplant Proc 2005;37:1240-1242.
38. Hubscher SG, Portmann BC. Transplantation pathology. In: MacSween RNM, Burt AD, Portmarm BC, Ishak KG, Scheuer PJ, Anthony PP, eds. Pathology of the Liver. Edinburgh, UK: Churchill Livingstone; 2002:885-941.
39. Mukherjee S, Rogge J, Weaver LK, Schafer DF. De novo cryptogenic hepatitis after sustained eradication of hepatitis C following liver transplantation. Transplant Proc 2004;36:1494-1497.
40. Evans HM, Kelly DA, McKiernan PJ, Hubscher S. Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology 2006;43:1109-1117.
41. Hubscher SG. Recurrent and de-novo disease in the liver allograft. Current Opinion in Organ Transplantation 2006;11:283-288.
42. Kemnitz; J, Gubernatis G, Bunzendahl H, Ringe B, Pichlmayr R, Georgii A. Criteria for the histopathological classification of liver allograft rejection and their clinical relevance. Transplant Proc 1989;21:2208-2210.
43. Snover DC, Freese DK, Sharp HL, Bloomer JR, Najarian JS, Ascher NL. Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection. Am J Surg Pathol 1987;11:1-10.
44. Cakaloglu Y, Devlin J, O'Grady J, Sutherland S, Portmarm BC, Heaton N, et al. Importance of concomitant viral infection during late acute liver allograft rejection. Transplantation 1995;59:40-45.
45. Mohamed R, Hubscher SG, Mirza DF, Gunson BK, Mutimer DJ. Posttransplantation chronic hepatitis in fulminant hepatic failure. Hepatology 1997;25:1003-1007.
46. Neuberger J. Liver transplantation for primary biliary cirrhosis: indications and risk of recurrence. J Hepatol 2003; 39:142-148.
47. Milkiewicz P, Hubscher SG, Skiba G, Hathaway M, Elias E. Recurrence of autoimmune hepatitis after liver transplantation. Transplantation 1999;68:253-256.
48. Graziadei IW, Wiesner RH, Batts KP, Marotta PJ, LaRusso NF, Porayko MK, et al. Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology 1999;29:1050-1056.
49. Wiesner RH, Sorrell M, Villamil F. Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C. Liver Transpl 2003;9(suppl):S1-S9.
50. Roche, B., Samuel, D. Evolving strategies to prevent HBV recurrence. Liver Transpl 2004; 10(suppl):S74-S85.
51. Brunt, E. M. Alcoholic and nonalcoholic steatohepatitis. Clin Liver Dis 2002;6:399-420.
52. Kerkar N, Hadzic N, Davies ET, Portmarm B, Donaldson PT, Rela M, et al. De-novo autoimmune hepatitis after liver transplantation. Lancet 1998;351:409-413.
53. Gupta P, Hart J, Millis JM, Cronin D, Brady L. De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation. Transplantation 2001;71:664-668.
54. Czaja AJ. Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance. Liver Transpl 2002;8:505-513.
55. Mieli-Vergani G, Vergani D. Autoimmune hepatitis in children. Clin Liver Dis 2002;6:623-634.
56. Jones DE, James OF, Portmann B, Burt AD, Williams R, Hudson M. Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis. Hepatology 1999;30:53-57.
57. Salcedo M, Vaquero J, Banares R, Rodriguez-Mahou M, Alvarez E, Vicario JL, et al. Response to steroids in de novo autoinimune hepatitis after liver transplantation. Hepatology 2002;35:349-356.
58. Pfau PR, Kochman ML, Lewis JD, Long WB, Lucey MR, Olthoff K, et al. Endoscopic management of postoperative biliary complications in orthotopic liver transplantation. Gastrointest Endosc 2000;52:55-63.
59. Nemec P, Ondrasek J, Studenik P, Hokl J, Cerny J. Biliary complications in liver transplantation. Ann Transplant 2001;6:24-28.
60. Gholson CF, Zibari G, McDonald JC. Endoscopic diagnosis and management of biliary complications following orthotopic liver transplantation. Dig Dis Sci 1996;41: 1045-1053.
61. Gow PJ, Mutimer D. Non-A, non-B fulminant hepatic failure. Arch Intern Med 2001;161:1013-1014.
62. Ben Ali Z, Samuel D, Zemel R, Baruch Y, Gigou M, Sikuler E, et al. Fulminant non-A-G viral hepatitis leading to liver transplantation. Arch Intern Med 2000;160:388-392.